Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,441 | 52,593 | 41,457 | 46,812 | 47,324 |
| Marketable Securities | 130,851 | 145,519 | 154,945 | 145,204 | 125,414 |
| TOTAL | $194,051 | $206,009 | $203,478 | $199,813 | $176,994 |
| Non-Current Assets | |||||
| PPE Net | 62,141 | 65,284 | 69,405 | 69,005 | 71,705 |
| Investments And Advances | 31,346 | 47,130 | 73,767 | 58,396 | 89,637 |
| Intangibles | 34,200 | 38,527 | 38,391 | 0 | 0 |
| Other Non-Current Assets | 31,478 | 31,667 | 31,405 | 21,293 | 22,355 |
| TOTAL | $159,165 | $182,608 | $212,968 | $148,694 | $183,697 |
| Total Assets | $353,216 | $388,617 | $416,446 | $348,507 | $360,691 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 82 | 209 | 350 | 491 | 584 |
| Accounts payable and accrued liabilities | 3,075 | 2,598 | 3,358 | 3,432 | 2,741 |
| Accrued Expenses | 17,461 | 13,444 | 11,095 | 7,532 | 10,149 |
| TOTAL | $129,782 | $19,820 | $19,163 | $16,065 | $17,846 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 20 | 20 | 20 | 56 |
| Deferred Revenues | 109,164 | 3,569 | 4,360 | 4,610 | 4,372 |
| Other Non-Current Liabilities | 57,698 | 59,820 | 62,025 | 44,251 | 46,658 |
| TOTAL | $62,072 | $173,111 | $175,179 | $154,559 | $158,095 |
| Total Liabilities | $191,854 | $192,931 | $194,342 | $170,624 | $175,941 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,045 | 85,029 | 84,716 | 82,847 | 64,818 |
| Common Shares | 9 | 9 | 8 | 6 | 6 |
| Retained earnings | -782,337 | -746,266 | -715,040 | -683,833 | -655,771 |
| Other shareholders' equity | 324 | 758 | -309 | -241 | 108 |
| TOTAL | $161,362 | $195,686 | $222,104 | $177,883 | $184,750 |
| Total Liabilities And Equity | $353,216 | $388,617 | $416,446 | $348,507 | $360,691 |